Life sciences briefing: Friday, Jan. 18, 2007
TODAY’S HEADLINES:
Ulthera receives $23M for cosmetic ultrasound devices (release)
Senexis raises £2.9M for Alzheimer’s drugs (PDF release)
Elixir Pharma postpones IPO (IPO Home)
Cancer Therapeutics names Randall Riggs as CEO (release)
Ulthera receives $23M for cosmetic ultrasound devices — Ulthera, a Mesa, Ariz., startup developing ultrasound systems for cosmetic… Continue Reading
Life sciences briefing: Monday, Oct. 29, 2007
Featured companies: Azaya Therapeutics, Global Care Solutions, Oxford Immunotec, RealSelf.com, Sequoia Pharmaceuticals, Tactile Systems Technology, WellGen, Zeltiq Aesthetics
UPDATED: Expanded items on Oxford Immunotec, Zeltiq, Tactile Systems, RealSelf.com and Global Care.
Oxford Immunotec pulls in $40M for TB tests — Oxford Immunotec, a U.K. biotech focused on new diagnostic… Continue Reading